In this study, we have used a large cohort of BC that express low levels of HER2 protein without evidence of HER2 gene amplification and applied an artificial neural network (ANN) model to refine the definition of HER2‐low class of BC with an emphasis on distinguishing HER2 score 1+ and 0 categories. This evidence concerns the gene ERBB2 and breast cancer.